Related-Party Transactions	12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]
Related-Party Transactions	16. Related-Party Transactions Teva Pharmaceuticals, Industries Ltd Teva Pharmaceuticals, Industries Ltd (“Teva”) was determined to be a related party because a member of the Company’s board of directors was the President and CFO of Teva Pharmaceuticals’ North America Commercial through June 2021. In addition, Teva was a non-significant shareholder of the Company during the year. Prior to the board member’s departure from the board of directors in June 2021, the Company recognized an immaterial amount of revenue from contracts with this client. During the year ended December 31, 2020, the Company recognized an immaterial amount of revenue from contracts with this client. Philips Holding USA, Inc. Philips Holding USA, Inc. (“Philips”) was determined to be a related party because a member of the Company’s board of directors was the Business Leader of Philips Population Health Management through June 2021. In addition, Philips is a non-significant shareholder of the Company. As of September 30, 2021, it was determined Philips was no longer a related party. Prior to the board member’s departure from Philips in June 2021, the Company recognized revenue of $1,658, from contracts with this client. During the year ended December 31, 2020, the Company recognized revenue of $2,441 from contracts with this client. Elevance Health Inc. (formerly Anthem) Elevance Health Inc. (“Elevance”) was determined to be a related party because a member of the Company’s board of directors served as the Vice President of Elevance through February 2021. In addition, Elevance is a non-significant shareholder of the Company. As of March 31, 2021, it was determined Elevance was no longer a related party. Prior to the board member’s departure from Elevance in February 2021, the Company recognized revenue of $7,218 from contracts with this client. During the year ended December 31, 2020 , the Company recognized revenue of $55,180 from contracts with this client. Cleveland Clinic Cleveland Clinic is a related party because a member of the Company’s board of directors is an executive advisor to Cleveland Clinic. As of December 31, 2022 and 2021, the Company held short-term deferred revenue of $355 and $456, respectively from contracts with this client. As of December 31, 2022 and 2021, amounts due from Cleveland Clinic were $995 and $441. During the years ended December 31, 2022, 2021 and 2020, the Company recognized revenue of $2,803, $1,301 and $1,357, respectively, from contracts with this client. CCAW, JV LLC CCAW, JV LLC is a related party because it is a joint venture formed between the Company and Cleveland Clinic for which the Company has a less than majority owned interest in. During the year ended December 31, 2020 the Company made an initial investment in CCAW, JV LLC of $2,940 for its less than 50% interest in the joint venture. During the years ended December 31, 2022 and 2021 the Company made a capital contributed of $1,960 and $2,548, related to a portion of the phase one capital commitment. During the year ended December 31, 2022, 2021 and 2020, the Company recognized revenue of $1,741, $1,841 and $1,825 from contracts with this client. As of December 31, 2022 and 2021, the Company held short and long term deferred revenue of $1,320 and $1,426 from contracts with this client. As of December 31, 2022 and 2021 amounts due from CCAW, JV LLC were $1,602 and $1,613, respectively.

Related-Party Transactions

12 Months Ended

Dec. 31, 2022

16. Related-Party Transactions

Teva Pharmaceuticals, Industries Ltd

Teva Pharmaceuticals, Industries Ltd (“Teva”) was determined to be a related party because a member of the Company’s board of directors was the President and CFO of Teva Pharmaceuticals’ North America Commercial through June 2021. In addition, Teva was a non-significant shareholder of the Company during the year.

Prior to the board member’s departure from the board of directors in June 2021, the Company recognized an immaterial amount of revenue from contracts with this client. During the year ended December 31, 2020, the Company recognized an immaterial amount of revenue from contracts with this client.

Philips Holding USA, Inc.

Philips Holding USA, Inc. (“Philips”) was determined to be a related party because a member of the Company’s board of directors was the Business Leader of Philips Population Health Management through June 2021. In addition, Philips is a non-significant shareholder of the Company. As of September 30, 2021, it was determined Philips was no longer a related party.

Prior to the board member’s departure from Philips in June 2021, the Company recognized revenue of $1,658, from contracts with this client. During the year ended December 31, 2020, the Company recognized revenue of $2,441 from contracts with this client.

Elevance Health Inc. (formerly Anthem)

Elevance Health Inc. (“Elevance”) was determined to be a related party because a member of the Company’s board of directors served as the Vice President of Elevance through February 2021. In addition, Elevance is a non-significant shareholder of the Company. As of March 31, 2021, it was determined Elevance was no longer a related party.

Prior to the board member’s departure from Elevance in February 2021, the Company recognized revenue of $7,218 from contracts with this client. During the year ended December 31, 2020 , the Company recognized revenue of $55,180 from contracts with this client.

Cleveland Clinic

Cleveland Clinic is a related party because a member of the Company’s board of directors is an executive advisor to Cleveland Clinic. As of December 31, 2022 and 2021, the Company held short-term deferred revenue of $355 and $456, respectively from contracts with this client. As of December 31, 2022 and 2021, amounts due from Cleveland Clinic were $995 and $441.

During the years ended December 31, 2022, 2021 and 2020, the Company recognized revenue of $2,803, $1,301 and $1,357, respectively, from contracts with this client.

CCAW, JV LLC

CCAW, JV LLC is a related party because it is a joint venture formed between the Company and Cleveland Clinic for which the Company has a less than majority owned interest in. During the year ended December 31, 2020 the Company made an initial investment in CCAW, JV LLC of $2,940 for its less than 50% interest in the joint venture. During the years ended December 31, 2022 and 2021 the Company made a capital contributed of $1,960 and $2,548, related to a portion of the phase one capital commitment.

During the year ended December 31, 2022, 2021 and 2020, the Company recognized revenue of $1,741, $1,841 and $1,825 from contracts with this client. As of December 31, 2022 and 2021, the Company held short and long term deferred revenue of $1,320 and $1,426 from contracts with this client. As of December 31, 2022 and 2021 amounts due from CCAW, JV LLC were $1,602 and $1,613, respectively.